drugset / Trial / NCT03925779

Conscious Sedation for Outpatient Colonoscopy

NCT03925779

Phase 2 Completed 80 enrolled Menoufia University
RandomizedParallel-groupDouble-blindOther

Summary

Although colonoscopy is a mildly painful procedure, the pain and the procedure itself are distressful for most patients. This raises the attention for using different sedation regimens aiming at maintaining optimal sedation level with maintained airway and stable haemodynamics all through the procedure. The present study was scheduled to investigate the sedative efficacy of dexmedetomedine versus propofol-remifentanil for outpatient colonoscopy.

Timeline

Start
2019-06-15
Primary completion
2020-12-31
Completion
2021-01-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Comparator Propofol Small molecule 25 ug/kg Intravenous
Comparator Propofol Small molecule 75 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.01 ug/kg
Comparator Remifentanil Small molecule 0.1 ug/kg

Indications

No indication recorded.